Haemonetics reports Q3 FY2024 results; specific figures not available in provided text

HAEMONETICS CORP

2024-Q3 EPS reported $1.89 revenue$965,765,000

Filed an 8-K on Feb 8, 2024, announcing Q3 and nine-month results for period ended Dec 30, 2023.
Press release issued as Exhibit 99.1 but full financial details are not included in the provided filing text.
Investor should refer to the complete press release for specific revenue, EPS, and segment data.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

HAEMONETICS CORP reported financial results for third quarter and nine months ended December 30, 2023.

Period: third quarter and nine months ended December 30, 2023
Result: reported results

Exact text from the filing

On February 8, 2024, Haemonetics Corporation issued a press release announcing financial results for the third quarter and nine months ended December 30, 2023.

View on SEC.gov

8 earnings releases filed in the last 30 days. Browse all earnings releases →

HAEMONETICS CORP filing history →

Source: SEC EDGAR

accession 0000313143-24-000006

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.